{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:07:06Z","timestamp":1791662826759,"version":"4.3.4"},"reference-count":16,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2017,10,8]],"date-time":"2017-10-08T00:00:00Z","timestamp":1507420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      High\u2010dose chemotherapy and autologous hematopoietic stem cell transplantation (auto\u2010\n                      <jats:styled-content style=\"fixed-case\">HCT<\/jats:styled-content>\n                      ) are commonly performed for multiple myeloma (\n                      <jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content>\n                      ) patients and may be as safe in the outpatient setting as in the inpatient setting.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We performed a single\u2010center retrospective analysis of all\n                      <jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content>\n                      patients undergoing auto\u2010\n                      <jats:styled-content style=\"fixed-case\">HCT<\/jats:styled-content>\n                      between January 2008 and December 2012. We categorized patients as outpatient vs inpatient auto\u2010\n                      <jats:styled-content style=\"fixed-case\">HCT<\/jats:styled-content>\n                      and compared clinical characteristics and outcomes between the groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      One thousand and forty\u2010six patients were included (669 inpatients, 377 outpatients). Patients transplanted as outpatients were significantly younger (58 [34\u201078] vs 62 [31\u201082],\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u00a0.001) and more likely to have an hematopoietic stem cell comorbidity index (\n                      <jats:styled-content style=\"fixed-case\">HCT<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      ) score &lt;2 (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a0.003) and creatinine &lt;2 (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u00a0.001). There were no differences in treatment\u2010related mortality (\n                      <jats:styled-content style=\"fixed-case\">TRM<\/jats:styled-content>\n                      ) but the inpatient group experienced significantly more grade 2\u20105 (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a0.003) and grade 3\u20105 (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a0.003) adverse events (\n                      <jats:styled-content style=\"fixed-case\">AE<\/jats:styled-content>\n                      s). 2\u00a0year progression\u2010free survival (\n                      <jats:styled-content style=\"fixed-case\">PFS<\/jats:styled-content>\n                      ) was significantly longer in the outpatient group (60% vs 50%,\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      =\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      0.7, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      0.6\u20100.9,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a0.005). 2\u00a0year\n                      <jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content>\n                      was also longer in the outpatient group (83% vs 77%,\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      0.6, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      04\u20100.9,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a0.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Outpatient auto\u2010\n                      <jats:styled-content style=\"fixed-case\">HCT<\/jats:styled-content>\n                      can be safely performed for selected patients with\n                      <jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content>\n                      . Differences in outcomes are likely related to baseline clinical characteristics rather than choice of treatment setting.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ejh.12970","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T02:43:49Z","timestamp":1505184229000},"page":"532-535","source":"Crossref","is-referenced-by-count":30,"title":["Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma"],"prefix":"10.1111","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1971-8173","authenticated-orcid":false,"given":"Nina","family":"Shah","sequence":"first","affiliation":[{"name":"Department of Medicine Hematology\u2010Oncology University of California San Francisco  San Francisco CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Megan","family":"Cornelison","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy University of Texas M.D. Anderson Cancer Center  Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Saliba","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy University of Texas M.D. Anderson Cancer Center  Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sairah","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy University of Texas M.D. Anderson Cancer Center  Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yago L.","family":"Nieto","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy University of Texas M.D. Anderson Cancer Center  Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qaiser","family":"Bashir","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy University of Texas M.D. Anderson Cancer Center  Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simrit","family":"Parmar","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy University of Texas M.D. Anderson Cancer Center  Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Hosing","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy University of Texas M.D. Anderson Cancer Center  Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Popat","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy University of Texas M.D. Anderson Cancer Center  Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Shpall","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy University of Texas M.D. Anderson Cancer Center  Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Champlin","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy University of Texas M.D. Anderson Cancer Center  Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffar","family":"Qazilbash","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy University of Texas M.D. Anderson Cancer Center  Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,10,8]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.20"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21387"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402888"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00389-7"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.79"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12225"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700900"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.4065\/83.10.1131"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2015.05.006"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-2004"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-300970"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3137-4"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23281"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155216639753"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.12.006"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.879"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fejh.12970","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.12970","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T13:13:42Z","timestamp":1696684422000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.12970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,8]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1111\/ejh.12970"],"URL":"https:\/\/doi.org\/10.1111\/ejh.12970","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,8]]}}}